Genes of the Human Leukocyte Antigen (HLA) system are associated with infectious, autoimmune and psychiatric diseases and cancer susceptibility. These genes have high level of polymorphism and present important diversity among different populations. To identify and relate HLA alleles with specific phenotypes, it is necessary to compare with a reference database of control individuals from the same population of origin of the patient sample studied. However, there are no HLA-reference databases for the Brazilian population. Therefore, we aim to determine HLAallele frequencies of control individuals from the Brazilian population for class I genes of HLA-A, -B and -C, and for class II genes of DPA1, DPB1, DQA1, DRB and DQB1. These results will be of paramount importance for further studies in our population
Introduction
The HLA-system is divided into three classes: I, II and III. The first two are similar in structure and function, coding for glycoproteins that act presenting antigen to T cells 1 . HLA class III genes encode molecules regulating humoral immunity and inflammatory reaction 2,3 . Class I genes encode the classic HLA-A, -B and -C molecules, while class II genes encode HLA-DR, HLA-DQ, HLA-DP, HLA DM and HLA-DO. The high level of polymorphism of the HLA-system genes is considered a selective advantage maintained by heterozygotes, increasing immune reaction against pathogens 4 . Copy Number Variants (CNV), duplications, inversions, translocalization and SNP-mutations in the HLA-system are believed to be involved in the susceptibility of more than a hundred diseases 4,5 . Therefore, it is very important to determine the distribution HLA subtypes in control population in order to carry out association studies aiming to investigate the relationship between HLA alleles and disease 6 .
Results and Discussion
We will determine HLA alleles in a group of 300 healthy individuals of the Brazilian population. Genotyping will be accomplished using the HLA sequencing panel TruSight v2 (Illumina®), or a similar one depending on the standardization experiments. DNA libraries will be prepared by isolating and amplifying 11 specific loci of the HLA-system. Subsequenlty, DNA-libraries will be sequenced on an MiSeq (Illumina®) platform.
Conclusions
We are currently working on the standardization of DNAsequencing procedures in order to amplifying class I genes: HLA-A, HLA-B and HLA-C, and: class II genes HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DRB and HLA-DQB1.
